Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 250Lymphoma 137Leukemia 124Burkitt Lymphoma 90Leukemia, Myeloid, Acute 69Lymphoma, Non-Hodgkin 65Lymphoma, Large B-Cell, Diffuse 59Myelodysplastic Syndromes 54Leukemia, Lymphocytic, Chronic, B-Cell 49Lymphoma, Mantle-Cell 47Hodgkin Disease 47Lymphoma, Follicular 45Leukemia, Myeloid, Accelerated Phase 39Multiple Myeloma 34Lymphoma, Large-Cell, Immunoblastic 33Leukemia, Myeloid, Chronic-Phase 33Recurrence 32Blast Crisis 32Lymphoma, B-Cell, Marginal Zone 31Congenital Abnormalities 31Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30Myeloproliferative Disorders 30Leukemia, Biphenotypic, Acute 30Graft vs Host Disease 30Leukemia, Myelomonocytic, Chronic 28Dendritic Cell Sarcoma, Interdigitating 25Neoplasms, Plasma Cell 22Primary Myelofibrosis 21Lymphoma, T-Cell, Cutaneous 20Lymphoma, Large-Cell, Anaplastic 20

Interventions

Zidovudine 2Vincristine 2Valganciclovir 2Rituximab 2Prednisone 2Etoposide 2Doxorubicin 2Cyclophosphamide 2tocilizumab 1tanespimycin 1liposomal doxorubicin 1ibrutinib 1deltacortene 1Sirolimus 1Polymerase Chain Reaction 1Methotrexate 1Interferon-alpha 1Hyaluronoglucosaminidase 1Histological Techniques 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1CT-P10 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multi-centric Castleman's Disease × Methotrexate × Lymphoid × Clear all
NCT03864419 2024-01-03

Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda

Fred Hutchinson Cancer Center

Phase 1 Terminated
18 enrolled
Lymphoid

Multi-centric Castleman's Disease, Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡